Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avricore Health (AVCRF) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Avricore Health (AVCRF) over the last 15 years, with Q3 2025 value amounting to $65584.4.

  • Avricore Health's Cost of Revenue fell 8823.31% to $65584.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $777141.9, marking a year-over-year decrease of 6388.03%. This contributed to the annual value of $2.1 million for FY2024, which is 2548.33% up from last year.
  • As of Q3 2025, Avricore Health's Cost of Revenue stood at $65584.4, which was down 8823.31% from $55418.1 recorded in Q2 2025.
  • Over the past 5 years, Avricore Health's Cost of Revenue peaked at $626512.5 during Q4 2023, and registered a low of $4683.7 during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $237166.1 (2023), whereas its average is $265979.5.
  • Per our database at Business Quant, Avricore Health's Cost of Revenue surged by 280141.12% in 2022 and then crashed by 8876.14% in 2025.
  • Over the past 5 years, Avricore Health's Cost of Revenue (Quarter) stood at $20526.0 in 2021, then surged by 2801.41% to $595543.3 in 2022, then rose by 5.2% to $626512.5 in 2023, then decreased by 5.03% to $594975.2 in 2024, then plummeted by 88.98% to $65584.4 in 2025.
  • Its Cost of Revenue stands at $65584.4 for Q3 2025, versus $55418.1 for Q2 2025 and $61164.2 for Q1 2025.